Exploring Shared Pathways: Anti-Cancer Drugs for Alzheimer’s Disease Management
Alzheimer’s disease (AD) and cancer exhibit several shared biological features, such as angiogenesis, mitochondrial dysfunction, and proteostasis, highlighting potential therapeutic opportunities. As the prevalence of…
CURATED BY: Eric Carlon, APRN, PMHNP-BC
Eric Carlon,
APRN, PMHNP-BC
Psychiatric Mental Health Nurse Practitioner, Home Physicians Group, Nova Southeastern University, Eastern Kentucky University, and Southern Adventist University
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive impairments that affect memory, decision-making, communication, and other aspects...
Promising Alzheimer’s Disease Treatments: Varied Results in Key Drug Trials
Recent randomized clinical trials have focused on three agents aimed at treating early Alzheimer's disease (AD), particularly with donanemab, aducanumab,...
Alzheimer’s Disease Treatment Breakthroughs: Emerging Therapies and Pathology Insights
This comprehensive analysis discusses Alzheimer's disease (AD), focusing on its growing prevalence, underlying pathologies, and current treatment strategies. The review...
